Biocryst Pharmaceuticals (BCRX) Operating Leases (2020 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Operating Leases came in at $13.0 million in Q1 2026, up 46.67% YoY from $8.8 million in Q1 2025, and up 51.44% on a QoQ basis from $8.6 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Operating Leases (2020 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 7 years of Operating Leases data on file, last reported at $13.0 million in Q1 2026.
- Quarterly Operating Leases rose 46.67% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.0 million (up 46.67% YoY) and the FY2025 annual result came in at $8.6 million, down 3.27% from the prior year.
- Operating Leases improved to $13.0 million in Q1 2026, from $8.6 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $13.0 million in Q1 2026 to a low of $5.5 million in Q4 2022.
- A 5-year average of $8.5 million and a median of $8.6 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases declined 28.76% — and 2023, when it surged 51.36%.
- Tracing BCRX's Operating Leases over 5 years: stood at $5.5 million in 2022, then surged by 51.36% to $8.4 million in 2023, then gained by 5.61% to $8.9 million in 2024, then decreased by 3.27% to $8.6 million in 2025, then soared by 51.44% to $13.0 million in 2026.
- The last three Operating Leases figures came in at $13.0 million (Q1 2026), $8.6 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Mn |
| Mar 31, 2026 | 12.98 Mn |
| Dec 31, 2025 | 8.57 Mn |
| Sep 30, 2025 | 8.77 Mn |
| Jun 30, 2025 | 8.88 Mn |
| Mar 31, 2025 | 8.85 Mn |
| Dec 31, 2024 | 8.86 Mn |
| Sep 30, 2024 | 9.11 Mn |
| Jun 30, 2024 | 9.39 Mn |
| Mar 31, 2024 | 8.60 Mn |
| Dec 31, 2023 | 8.39 Mn |
| Sep 30, 2023 | 12.25 Mn |
| Jun 30, 2023 | 8.33 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 5.54 Mn |
| Sep 30, 2022 | 8.16 Mn |
| Jun 30, 2022 | 6.20 Mn |
| Mar 31, 2022 | 6.46 Mn |
| Dec 31, 2021 | 7.78 Mn |
| Dec 31, 2020 | 3.87 Mn |